跳至主要内容
临床试验/NL-OMON36142
NL-OMON36142已完成不适用

Safety and immunogenicity of seasonal and pandemic inactivated whole virion influenza vaccine in healthy adults - Safety and immunogenicity of whole virion influenza vaccines

Stichting Leveronderzoek0 个研究点目标入组 120 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
120

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • Age 18 to 49 years
  • Good health according to the investigator

排除标准

  • - having had an infectious disease with fever (including influenza) within the last 14 days
  • - present evidence of serious disease(s) demanding medical treatment that might interfere with the results of the study such as diseases which interfere with the immune system
  • - known or suspected allergy to any of the vaccine components: egg components, chicken protein, ovalbumin (by medical history)
  • - known or suspected immune deficiency
  • - history of any neurologic disorder, including epilepsy
  • - females: positive pregnancy test
  • - positive HIV, HBV or HCV serology
  • - previous vaccination with an influenza vaccine in the previous three winter seasons
  • - abnormal pre-treatment laboratory parameters which are clinically relevant according to the investigator

研究者

发起方
Stichting Leveronderzoek

相似试验